Dr. Alper Dincer

Christopher Hong is a Neurosurgery provider in Boston, Massachusetts. Dr. Hong is rated as an Advanced provider by MediFind in the treatment of Pineocytoma. His top areas of expertise are Hypothalamic Tumor, Brain Tumor, Pituitary Tumor, Spinal Fusion, and Laminectomy. Dr. Hong is currently accepting new patients.

Mansour Mathkour is a Neurosurgery provider in Providence, Rhode Island. Dr. Mathkour is rated as an Advanced provider by MediFind in the treatment of Pineocytoma. His top areas of expertise are Chiari Malformation Type 2, Chiari Malformation, Split Spinal Cord Malformation, Deep Brain Stimulation, and Posterior Fossa Decompression.

Dr. Brian Nahed is a neurosurgeon specializing in Brain Tumors (Glioblastoma, Low Grade Gliomas, Meningiomas, Metastatic Brain Tumors) and Brain Mapping / Intraoperative Imaging. He is Director of Neurosurgery Residency Program at MGH and Harvard Medical School and Associate Professor of Neurosurgery.Patient appointments: 617-724-5805. (Appointments / Second Opinions within 24 hrs.) Visit my web page.Dr. Nahed specializes in brain tumors of the eloquent cortex (language and motor areas of the brain) which require awake surgery, language and motor mapping, and subcortical stimulation. Dr. Nahed specializes in intraoperative technology and minimally invasive procedures to treat brain tumors aggressively and safely.Born in New York, Dr. Nahed attended UCLA where he majored in Neuroscience, graduating Phi Beta Kappa and with the department's Highest Honors. He attended the Yale School of Medicine where he was awarded the Doris Duke Clinical Research Fellowship and graduated with honors. Dr. Nahed completed his neurosurgery residency at the Massachusetts General Hospital; where Dr. Nahed completed a postdoctoral fellowship with Drs. Daniel Haber and Shyamala Maheswaran in the MGH Cancer Center.Dr. Brian Nahed was recruited to the MGH Department of Neurosurgery, MGH Brain Tumor Center, and Harvard Medical School in 2011. Dr. Brian Nahed's research focuses on developing the first blood based test to diagnose and monitor brain tumors. In collaboration with Drs. Haber, Maheswaran, and Stott, Dr. Nahed published the first evidence of circulating tumor cells in the blood of patients with glioblastoma. Drs Nahed and Stott run an NIH funded laboratory developing the first blood test for patients with brain tumors.As the Director of the MGH Neurosurgery Residency Program, he has led neurosurgical education. He serves on the Executive Committee of the Congress of Neurological Surgeons and the CNS/AANS Executive Committee For Brain Tumors. He is Co-Chair of the CNS Leadership Institute. He is an active member of the American Association of Neurological Surgeons and Council State Neurological Societies. Dr. Nahed serves as the lead neurotrauma consultant for the National Football League (NFL). Dr. Nahed is rated as an Elite provider by MediFind in the treatment of Pineocytoma. His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, Awake Craniotomy, and Thrombectomy.